Intuitive Surgical, Inc. (ISRG) Ascends While Market Falls: Some Facts to Note
Werte in diesem Artikel
Intuitive Surgical, Inc. (ISRG) ended the recent trading session at $524.03, demonstrating a +0.4% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of 0.22%. Meanwhile, the Dow lost 0.36%, and the Nasdaq, a tech-heavy index, lost 0.16%.Prior to today's trading, shares of the company had lost 5.09% over the past month. This has was narrower than the Medical sector's loss of 6.83% and lagged the S&P 500's loss of 2.36% in that time.Analysts and investors alike will be keeping a close eye on the performance of Intuitive Surgical, Inc. in its upcoming earnings disclosure. The company is predicted to post an EPS of $1.76, indicating a 10% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.21 billion, up 14.53% from the year-ago period.Investors should also take note of any recent adjustments to analyst estimates for Intuitive Surgical, Inc. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.03% higher. Intuitive Surgical, Inc. currently has a Zacks Rank of #3 (Hold).From a valuation perspective, Intuitive Surgical, Inc. is currently exchanging hands at a Forward P/E ratio of 66.53. This expresses a premium compared to the average Forward P/E of 26.77 of its industry.Investors should also note that ISRG has a PEG ratio of 3.56 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Medical - Instruments industry was having an average PEG ratio of 2.The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 71, putting it in the top 29% of all 250+ industries.The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com.Just Released: Zacks Top 10 Stocks for 2024Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Intuitive Surgical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Intuitive Surgical Inc
Analysen zu Intuitive Surgical Inc
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
26.01.2018 | Intuitive Surgical Hold | Canaccord Adams | |
18.07.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets | |
30.06.2017 | Intuitive Surgical Neutral | Cantor Fitzgerald | |
30.05.2017 | Intuitive Surgical Hold | Canaccord Adams | |
17.04.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
23.01.2015 | Intuitive Surgical Sell | CRT Capital | |
22.10.2014 | Intuitive Surgical Sell | CRT Capital | |
09.01.2009 | Intuitive Surgical Downgrade | Brean Murray, Carret & Co., LLC | |
26.08.2005 | Update Intuitive Surgical Inc. : Underperform | Jefferies & Co |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen